Smith & Nephew (SNNUF) EPS (Weighted Average and Diluted) (2009 - 2024)

Smith & Nephew (SNNUF) reported EPS (Weighted Average and Diluted) of $24.5 for Q4 2024, up 128.74% on a YoY basis from $10.71 in Q1 2024, and up 128.74% quarter-over-quarter from $10.71 in Q4 2023.

Smith & Nephew (SNNUF) EPS (Weighted Average and Diluted) (2009 - 2024) Analysis & Trends

Smith & Nephew has reported EPS (Weighted Average and Diluted) for 10 years, with the latest figure at $24.5 in Q4 2024.

  • For the quarter ending Q4 2024, EPS (Weighted Average and Diluted) rose 128.74% year-over-year to $24.5; the trailing twelve-month figure through Dec 2024 stood at $58.5 (up 446.18% YoY), and the FY2025 full-year result was $0.72, up 52.34% from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2024 stood at $24.5, up from $10.71 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $24.5 in Q4 2024, with the low at $10.71 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.61
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.93
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.89
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.85
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 2.24
10 Smith & Nephew - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 24.50
Dec 31, 2023 10.71
Dec 31, 2016 12.16
Dec 31, 2015 9.01
Dec 31, 2014 18.44
Sep 30, 2014 4.04
Mar 31, 2014 11.91
Dec 31, 2013 3.32
Mar 31, 2013 12.89
Jun 30, 2012 9.52
Mar 31, 2012 14.30
Dec 31, 2011 -9.82
Sep 30, 2011 3.81
Jun 30, 2011 7.59
Mar 31, 2011 12.62
Dec 31, 2010 3.38
Sep 30, 2010 0.00
Jun 30, 2010 -7.77
Mar 31, 2010 16.75
Dec 31, 2009 2.74